Dashboard
Manage Tickers

SGMO SANGAMO THERAPEUTICS, INC


$ 0.67 $ 0.00 (0 %)    

Tuesday, 14-Oct-2025 05:43:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 0.69
$ 0.66 x 100
$ 0.68 x 1
-- - --
$ 0.41 - $ 3.18
5,206,962
na
203.8M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

on-september-9-sangamo-therapeutics-cfo-prathyusha-duraibabu-resigned
On September 9, Sangamo Therapeutics CFO P...
09/11/2025 21:08:32

-SEC Filing

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
09/04/2025 16:12:59

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $...

sangamo-therapeutics-q2-eps-008-misses-005-estimate-sales-18306m-miss-31680m-estimate
Sangamo Therapeutics Q2 EPS $(0.08) Misses...
08/07/2025 20:08:37

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
'South Africa, Gates Foundation Pledge Fun...
08/04/2025 16:40:22

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
06/24/2025 16:40:14

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

sangamo-therapeutics-announces-topline-results-from-registrational-phase-12-staar-of-st-920-in-fabry-disease-intends-to-submit-biologics-license-application-in-2026
Sangamo Therapeutics Announces Topline Res...
06/24/2025 12:10:25

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dose...

barclays-maintains-overweight-on-sangamo-therapeutics-lowers-price-target-to-5
Barclays Maintains Overweight on Sangamo T...
05/14/2025 15:07:44

Barclays analyst Gena Wang maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Overweight and lowers the price target from $...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 17:06:46

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

us-stocks-likely-to-open-lower-after-a-strong-rally-lows-are-likely-in-and-better-times-are-coming-says-expert
US Stocks Likely To Open Lower After A Str...
05/13/2025 09:45:38

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in pr...

why-coinbase-global-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket
Why Coinbase Global Shares Are Trading Hig...
05/13/2025 09:28:26

sangamo-therapeutics-q1-eps-014-misses-013-estimate-sales-644m-miss-742m-estimate
Sangamo Therapeutics Q1 EPS $(0.14) Misses...
05/12/2025 22:38:35

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

sangamo-therapeutics-prices-23m-underwritten-offering-of-12235m-shares-of-common-stock-and-pre-funded-warrants-at-050-and-049-respectively-including-accompanying-warrants-exercisable-at-075
Sangamo Therapeutics Prices $23M Underwrit...
05/12/2025 22:25:23

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced the pricing of an underwritten offering c...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
05/12/2025 21:06:02

sangamo-therapeutics-q1-gaap-eps-014-misses-013-estimate-sales-644m-miss-742m-estimate
Sangamo Therapeutics Q1 GAAP EPS $(0.14) M...
05/12/2025 20:37:08

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

sangamo-therapeutics-announces-derisking-milestones-for-pathway-to-anticipated-bla-submission-for-st-920-in-fabry-disease
Sangamo Therapeutics Announces Derisking M...
05/06/2025 12:36:00

All dosed patients have passed one-year milestone required by U.S. Food and Drug Administration (FDA) for Accelerated Approval ...

sangamo-therapeutics-to-present-at-28th-annual-meeting-of-the-american-society-of-gene--cell-therapy-may-13-17
Sangamo Therapeutics To Present At 28th An...
04/28/2025 20:33:14

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
04/07/2025 12:48:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION